Golden Meditech Holdings Ltd filings

This page lists the SEC filings reported by Golden Meditech Holdings Ltd.

SEC filings by Golden Meditech Holdings Ltd (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2015-04-27Golden Meditech Holdings LtdChina Cord Blood Corp30,681,26638.3%EDGAR
SC 13D/A2014-08-25Golden Meditech Holdings LtdChina Cord Blood Corp30,681,26642.0%EDGAR
SC 13D/A2013-07-11Golden Meditech Holdings LtdChina Cord Blood Corp30,681,26642.0%EDGAR
SC 13D/A2012-10-04Golden Meditech Holdings LtdChina Cord Blood Corp30,561,51641.8%EDGAR
SC 13D/A2012-05-02Golden Meditech Holdings LtdChina Cord Blood Corp30,248,98341.4%EDGAR
SC 13D/A2012-04-12Golden Meditech Holdings LtdChina Cord Blood Corp30,248,98341.3%EDGAR
SC 13D/A2011-09-30Golden Meditech Holdings LtdChina Cord Blood Corp30,119,62640.9%EDGAR
SC 13D/A2011-06-23Golden Meditech CO LTDChina Cord Blood Corp29,822,87839.5%EDGAR
SC 13D2009-07-09Golden Meditech CO LTDChina Cord Blood Corp29,068,08749.0%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.